📊 VANI Key Takeaways
Is Vivani Medical, Inc. (VANI) a Good Investment?
Vivani Medical is a pre-revenue company with severe operational losses of $6.8M and negative operating cash flow of $6.2M, indicating unsustainable burn with no demonstrated commercial traction. Despite holding $19.7M in cash and zero debt, the company will deplete resources within 3-4 years at current burn rates unless revenue materializes immediately. The complete absence of revenue in a medical device company raises fundamental questions about product viability and market acceptance.
Vivani Medical, Inc. Key Strengths (VANI)
- Strong cash position of $19.7M provides 3-4 year operational runway
- Zero debt eliminates refinancing risk and provides financial flexibility
- Excellent liquidity ratios (3.18x current, 3.14x quick) ensure near-term solvency
VANI Stock Risks: Vivani Medical, Inc. Investment Risks
- Zero revenue indicates complete absence of commercial traction or product-market fit
- Operating cash burn of $6.2M annually is unsustainable without revenue offsetting costs
- Medical device sector requires significant capital investment with no guarantee of regulatory approval or market adoption
- Negative ROE (-35.5%) and ROA (-16.0%) demonstrate systematic destruction of shareholder and asset value
- Cash depletion timeline creates existential threat if revenue generation does not occur within 3-4 years
Key Metrics to Watch
- Revenue recognition - any movement from $0 is critical signal
- Operating cash flow trend - must turn positive to demonstrate path to profitability
- Monthly cash burn rate - acceleration would accelerate timeline to insolvency
Vivani Medical, Inc. (VANI) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 3.18x current ratio provides a solid financial cushion.
VANI Profit Margin, ROE & Profitability Analysis
VANI vs Healthcare Sector: How Vivani Medical, Inc. Compares
How Vivani Medical, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Vivani Medical, Inc. Stock Overvalued? VANI Valuation Analysis 2026
Based on fundamental analysis, Vivani Medical, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Vivani Medical, Inc. Balance Sheet: VANI Debt, Cash & Liquidity
VANI Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Vivani Medical, Inc.'s revenue has declined by 100% over the 5-year period, indicating business contraction. The most recent EPS of $-0.43 indicates the company is currently unprofitable.
VANI Revenue Growth, EPS Growth & YoY Performance
VANI Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2025 | N/A | -$5.4M | $-0.10 |
| Q1 2025 | N/A | -$6.0M | $-0.11 |
| Q3 2024 | N/A | -$5.4M | $-0.11 |
| Q2 2024 | N/A | -$5.4M | $-0.10 |
| Q2 2021 | N/A | -$2.3M | N/A |
| Q3 2020 | $472.0K | -$1.6M | N/A |
| Q2 2020 | $1.3M | -$3.1M | N/A |
| Q1 2020 | $1.1M | -$8.9M | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Vivani Medical, Inc. Dividends, Buybacks & Capital Allocation
VANI SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Vivani Medical, Inc. (CIK: 0001266806)
📋 Recent SEC Filings
❓ Frequently Asked Questions about VANI
What is the AI rating for VANI?
Vivani Medical, Inc. (VANI) has an AI grade of D with 92% confidence, based on fundamental analysis of SEC EDGAR filings.
What are VANI's key strengths?
Claude: Strong cash position of $19.7M provides 3-4 year operational runway. Zero debt eliminates refinancing risk and provides financial flexibility.
What are the risks of investing in VANI?
Claude: Zero revenue indicates complete absence of commercial traction or product-market fit. Operating cash burn of $6.2M annually is unsustainable without revenue offsetting costs.
What is VANI's revenue and growth?
Vivani Medical, Inc. reported revenue of $0.0.
Does VANI pay dividends?
Vivani Medical, Inc. does not currently pay dividends.
Where can I find VANI SEC filings?
Official SEC filings for Vivani Medical, Inc. (CIK: 0001266806) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is VANI's EPS?
Vivani Medical, Inc. has a diluted EPS of $-0.08.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is VANI's fundamental grade?
Based on our AI fundamental analysis in June 2026, Vivani Medical, Inc. has a D grade with 92% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is VANI stock overvalued or undervalued?
Valuation metrics for VANI: ROE of -35.5% (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is VANI's AI grade for 2026?
Our dual AI analysis gives Vivani Medical, Inc. a combined D grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is VANI's free cash flow?
Vivani Medical, Inc.'s operating cash flow is $-6.2M, with capital expenditures of $3.0K.
How does VANI compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE -35.5% (avg: 15%), current ratio 3.18 (avg: 2).